Standout Papers

Mechanisms of NAFLD developme... 2000 2026 2008 2017 2.9k
  1. Mechanisms of NAFLD development and therapeutic strategies (2018)
    Scott L. Friedman, Brent A. Neuschwander‐Tetri et al. Nature Medicine
  2. Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver (2008)
    Scott L. Friedman Physiological Reviews
  3. Mechanisms of Hepatic Fibrogenesis (2008)
    Scott L. Friedman Gastroenterology
  4. Mechanisms of hepatic stellate cell activation (2017)
    Takuma Tsuchida, Scott L. Friedman Nature Reviews Gastroenterology & Hepatology
  5. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury (2000)
    Scott L. Friedman Journal of Biological Chemistry
  6. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis (2015)
    Eduardo Vilar‐Gómez, Luis Calzadilla Bertot et al. Gastroenterology
  7. Liver fibrosis – from bench to bedside (2003)
    Scott L. Friedman Journal of Hepatology
  8. Pathogenesis of Liver Fibrosis (2011)
    Virginia Hernández–Gea, Scott L. Friedman Annual Review of Pathology Mechanisms of Disease
  9. The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies (1993)
    Scott L. Friedman et al. New England Journal of Medicine
  10. Mechanisms and disease consequences of nonalcoholic fatty liver disease (2021)
    Rohit Loomba, Scott L. Friedman et al. Cell
  11. Hepatic stellate cells as key target in liver fibrosis (2017)
    Takaaki Higashi, Scott L. Friedman et al. Advanced Drug Delivery Reviews
  12. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis (2016)
    Daniela Sia, Augusto Villanueva et al. Gastroenterology
  13. Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma (2009)
    Yujin Hoshida, Sebastian Nijman et al. Cancer Research
  14. Mechanisms of hepatic fibrogenesis (2011)
    Scott L. Friedman et al. Best Practice & Research Clinical Gastroenterology
  15. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. (1985)
    Scott L. Friedman, F J Roll et al. Proceedings of the National Academy of Sciences
  16. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs (1998)
    Martina Müller, Sylvia Wilder et al. The Journal of Experimental Medicine
  17. Pathobiology of liver fibrosis: a translational success story (2015)
    Youngmin A. Lee, M. Christopher Wallace et al. Gut
  18. Senolytic CAR T cells reverse senescence-associated pathologies (2020)
    Corina Amor, Judith Feucht et al. Nature
  19. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features (2017)
    Daniela Sia, Yang Jiao et al. Gastroenterology
  20. Hepatic Stellate Cells and Liver Fibrosis (2013)
    Juan Enrique Puche, Yedidya Saiman et al. Comprehensive physiology
  21. Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma (2013)
    Virginia Hernández–Gea, Sara Toffanin et al. Gastroenterology
  22. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma† (2007)
    Elisa Wurmbach, Ying‐Bei Chen et al. Hepatology
  23. Hepatic fibrosis: Concept to treatment (2015)
    Christian Trautwein, Scott L. Friedman et al. Journal of Hepatology
  24. Therapy for Fibrotic Diseases: Nearing the Starting Line (2013)
    Scott L. Friedman, Dean Sheppard et al. Science Translational Medicine
  25. Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues (2012)
    Virginia Hernández–Gea, Zahra Ghiassi–Nejad et al. Gastroenterology
  26. Evolving challenges in hepatic fibrosis (2010)
    Scott L. Friedman Nature Reviews Gastroenterology & Hepatology
  27. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine (2017)
    Naoto Fujiwara, Scott L. Friedman et al. Journal of Hepatology
  28. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer (2018)
    Takuma Tsuchida, Youngmin A. Lee et al. Journal of Hepatology
  29. Functions of autophagy in normal and diseased liver (2013)
    Mark J. Czaja, Wen-Xing Ding et al. Autophagy
  30. Size, shape, and composition of luminescent species in oxidized Si nanocrystals and H-passivated porous Si (1995)
    S. Schuppler, Scott L. Friedman et al. Physical review. B, Condensed matter
  31. The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells (2020)
    Parth Trivedi, Shuang Wang et al. Cell Metabolism
  32. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future (2021)
    Scott L. Friedman, Massimo Pinzani Hepatology
  33. Dimensions of luminescent oxidized and porous silicon structures (1994)
    S. Schuppler, Scott L. Friedman et al. Physical Review Letters
  34. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment (2023)
    Josep M. Llovet, Catherine E. Willoughby et al. Nature Reviews Gastroenterology & Hepatology
  35. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023)
    Frank Tacke, Tobias Puengel et al. Journal of Hepatology
  36. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis (2023)
    Shuang Wang, Ross Dobie et al. Science Translational Medicine
  37. Friend or foe? The elusive role of hepatic stellate cells in liver cancer (2023)
    Bruno Cogliati, Chittampalli N. Yashaswini et al. Nature Reviews Gastroenterology & Hepatology
  38. Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis (2024)
    Chittampalli N. Yashaswini, Dipankar Bhattacharya et al. Journal of Hepatology

Immediate Impact

4 by Nobel laureates 15 from Science/Nature 134 standout
Sub-graph 1 of 20

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
42 intermediate papers

Works of Scott L. Friedman being referenced

Therapy for Fibrotic Diseases: Nearing the Starting Line
2013 Standout
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
1985 Standout
and 50 more

Author Peers

Author Last Decade Papers Cites
Scott L. Friedman 30129 31616 17799 431 60.2k
David A. Brenner 21617 26184 19833 507 58.1k
David E. Kleiner 17152 31134 7768 510 49.1k
Gregory J. Gores 18678 19761 19055 583 61.8k
Anna Mae Diehl 15918 34550 13091 405 50.2k
Frank Tacke 15955 21618 8919 695 43.6k
Masao Omata 19210 17387 9861 1.0k 49.9k
Elizabeth M. Brunt 17176 38092 8024 268 48.9k
Christian Trautwein 12695 14942 9567 700 35.2k
Rohit Loomba 19761 38376 8268 687 47.8k
Bin Gao 6701 14402 11002 478 35.3k

All Works

Loading papers...

Rankless by CCL
2026